LATHAM, N.Y. (AP) _ AngioDynamics Inc. (ANGO) on Thursday reported a loss of $8.4 million in its fiscal second quarter.

On a per-share basis, the Latham, New York-based company said it had a loss of 21 cents. Losses, adjusted for one-time gains and costs, came to 2 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was breakeven on a per-share basis.

The medical device maker posted revenue of $78.3 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $78 million.

AngioDynamics expects full-year results to range from a loss of 2 cents per share to earnings of 2 cents per share, with revenue in the range of $310 million to $315 million.

AngioDynamics shares have climbed almost 1% since the beginning of the year. The stock has risen 79% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANGO at https://www.zacks.com/ap/ANGO

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News